Iatrogenic hyperkalaemia--points to consider in diagnosis and management.
作者信息
Siamopoulos K C, Elisaf M, Katopodis K
机构信息
Department of Internal Medicine, University Hospital of Ioannina, Greece.
出版信息
Nephrol Dial Transplant. 1998 Sep;13(9):2402-6. doi: 10.1093/ndt/13.9.2402.
PMID:9761538
Abstract
摘要
相似文献
1
Iatrogenic hyperkalaemia--points to consider in diagnosis and management.
Nephrol Dial Transplant. 1998 Sep;13(9):2402-6. doi: 10.1093/ndt/13.9.2402.
2
3
Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.血管紧张素转换酶抑制剂和利尿剂引起的危及生命的高钾血症。
Diabet Med. 1997 Feb;14(2):169-70. doi: 10.1002/(SICI)1096-9136(199702)14:2<169::AID-DIA307>3.0.CO;2-5.
4
Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.一名肺移植患者中，甲氧苄啶与血管紧张素转换酶抑制剂联合使用导致严重高钾血症。
J Intern Med. 1996 Oct;240(4):249-51. doi: 10.1046/j.1365-2796.1996.43869000.x.
5
Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
Diabet Med. 1997 Sep;14(9):808. doi: 10.1002/(SICI)1096-9136(199709)14:9<808::AID-DIA464>3.0.CO;2-2.
6
Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.螺内酯 + 血管紧张素转换酶抑制剂或沙坦类药物：高钾血症风险
Prescrire Int. 2004 Apr;13(70):58.
7
Hyperkalemia and trimethoprim-sulfamethoxazole.高钾血症与甲氧苄啶-磺胺甲恶唑
Ann Intern Med. 1996 Nov 1;125(9):778; author reply 779-80. doi: 10.7326/0003-4819-125-9-199611010-00021.
8
[Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].螺内酯和血管紧张素转换酶抑制剂治疗导致的药物相关性高钾血症
Pol Merkur Lekarski. 1999 Aug;7(38):69-70.
9
Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.血管紧张素转换酶抑制剂与螺内酯联合治疗期间的危及生命的高钾血症。
Am J Med. 2001 Nov;111(7):587. doi: 10.1016/s0002-9343(01)00927-5.
10
Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
J Hum Hypertens. 1999 Oct;13(10):717-20. doi: 10.1038/sj.jhh.1000890.
引用本文的文献
1
Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs.犬类接受血管紧张素转换酶抑制剂治疗后肾功能恶化危险因素的回顾性评估。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17252. doi: 10.1111/jvim.17252. Epub 2024 Nov 20.
2
Severe hyperkalaemia: demographics and outcome.严重高钾血症：人口统计学特征与结局
Clin Kidney J. 2014 Apr;7(2):127-33. doi: 10.1093/ckj/sft158. Epub 2014 Jan 2.
3
Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.低清除率门诊随访的透析前患者高钾血症的患病率及相关因素。
Clin J Am Soc Nephrol. 2012 Aug;7(8):1234-41. doi: 10.2215/CJN.01150112. Epub 2012 May 17.
Zotero 插件